Suggests empiric vitamin D supplementation to lower mortality risk in adults aged 75 years and older. Triggered by clinician questions such as “Should I prescribe vitamin D to this elderly patient?” or “Is vitamin D supplementation indicated for patients over 75?”
Scanned 9/9/2026
Install to Claude Code
npx -y skills add dromlakhani/MD2SKILL --skill endo-vitd-supplementation-over75 --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Endo Vitd Supplementation Over75?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/dromlakhani-endo-vitd-supplementation-over75)More formats (shields.io, HTML) on the badges page.
---
name: endo-vitd-supplementation-over75
description: Suggests empiric vitamin D supplementation to lower mortality risk in adults aged 75 years and older. Triggered by clinician questions such as “Should I prescribe vitamin D to this elderly patient?” or “Is vitamin D supplementation indicated for patients over 75?”
---
# Vitamin D supplementation for adults over 75
## STEP 1 — Gather Information
Confirm patient age ≥75 years, absence of established indications for vitamin D treatment or 25(OH)D testing (e.g., no malabsorption, renal osteodystrophy, granulomatous disease, hypercalcemia, or current vitamin D deficiency therapy), and assess current vitamin D supplement use; determine eligibility for empiric supplementation.
## STEP 2 — Rule In / Rule Out
If the patient is ≥75 years and generally healthy without contraindications, proceed; otherwise, do not recommend empiric vitamin D supplementation for mortality prevention and consider alternative indications or testing.
## STEP 3 — Classify or Stratify
Classify preferred dosing regimen: daily lower-dose vitamin D (preferred) versus nondaily higher-dose regimens; choose daily lower-dose vitamin D as the preferred regimen.
## STEP 4 — Decide
Prescribe empiric vitamin D supplementation via daily lower-dose (e.g., 800–1000 IU vitamin D3 per day) and advise against routine 25(OH)D testing.
## Clinical Guardrails / Mimics / Pitfalls
Do not use in patients with conditions that alter vitamin D metabolism (malabsorption, renal failure, granulomatous diseases, hypercalcemia); avoid high bolus dosing; do not rely on 25(OH)D levels to guide dosing; do not extrapolate to those with established indications for vitamin D treatment; supplementation is inexpensive and feasible but should not replace dietary intake when adequate.
## Concrete Clinical Example
A 78‑year‑old woman without malabsorption, renal disease, or hypercalcemia asks whether she should take vitamin D to lower her mortality risk; she is not currently taking a supplement. Recommend initiating daily vitamin D3 800–1000 IU and counsel against routine 25(OH)D testing.
**Source:** Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, DOI:10.1210/clinem/dgae290
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!